ONCOONE
OncoOne is a biotech start-up dedicated to developing innovative therapeutics to treat patients with solid tumors, founded by three individuals with a long history in drug development and oncology research from the pharmaceutical industry.
ONCOONE
Industry:
Biotechnology Therapeutics
Founded:
2018-01-01
Address:
Klosterneuburg, Niederosterreich, Austria
Country:
Austria
Website Url:
http://www.oncoone.com
Total Employee:
1+
Status:
Active
Total Funding:
13 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Apache Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online
Current Employees Featured
Founder
Investors List
aws Fondsmanagement GmbH
aws Fondsmanagement GmbH investment in Series A - OncoOne
The Austrian Research Promotion Agency (FFG)
The Austrian Research Promotion Agency (FFG) investment in Series A - OncoOne
Official Site Inspections
http://www.oncoone.com
- Host name: s3474.fra1.stableserver.net
- IP address: 192.250.229.115
- Location: Las Vegas United States
- Latitude: 36.1682
- Longitude: -115.2166
- Metro Code: 839
- Timezone: America/Los_Angeles
- Postal: 89107
More informations about "OncoOne"
OncoOne - Crunchbase Company Profile & Funding
Organization. OncoOne . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. OncoOne is a biotech start-up dedicated to developing innovative therapeutics. ... OncoOne is a …See details»
OncoOne - LinkedIn
OncoOne | 2,769 followers on LinkedIn. The world’s leaders in oxMIF targeted therapies against the macrophage migration inhibitory factor. www.OncoOne.com | OncoOne is a biotech start …See details»
Our Founders - OncoOne
OncoOne’s approach is designed to overcome limitations in current systemic therapeutics and address chronic inflammatory diseases and cancer, with the ambition to effectively improve …See details»
OncoOne - Vienna BioCenter
OncoOne has established a strong patent portfolio with additional IP in preparation. Go to website. Contact OncoOne Research & Development GmbH. Karl-Farkas-Gasse 22, 1.OG …See details»
OncoOne Company Profile - Office Locations, Competitors ... - Craft
OncoOne has 5 employees across 2 locations and $14.39 m in total funding,. See insights on OncoOne including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
OncoOne - Products, Competitors, Financials, Employees, …
OncoOne. Frequently Asked Questions (FAQ) When was OncoOne founded? OncoOne was founded in 2018. Where is OncoOne's headquarters? OncoOne's headquarters is located at …See details»
OncoOne - Funding, Financials, Valuation & Investors - Crunchbase
OncoOne is a biotech start-up dedicated to developing innovative therapeutics. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. ...See details»
OncoOne - Contacts, Employees, Board Members, Advisors
OncoOne has 3 current employee profiles, including Co-Founder, Managing Director & Chief Executive Officer Randolf Kerschbaumer. Randolf Kerschbaumer Co-Founder, Managing …See details»
Leadership - OncoOne
Our Leadership About Us OncoOne Assembles a Team With the Perfect Blend of Experience, Precisely When It’s Needed The leadership team at OncoOne comprises seasoned …See details»
Life Sciences Directory: OncoOne Research
OncoOne Research Back to list. Facts. Founded 2018 Staff 10 Organization type RDM biotech/pharma Region Lower Austria Focus human health Profile. Please visit our website: …See details»
OncoOne Research & Development GmbH - Life-Sciences …
Jun 1, 2018 "Press Release: OncoOne Launches with EUR 13 Million Series A to Develop Multiple Drug Modalities for Unexplored Target". Klosterneuburg.... To subscribe to our free, …See details»
Antibody Engineering - OncoOne
At OncoOne, our world-class team of antibody engineers develop and optimize unique, tailored antibodies (mAbs) with precisely defined functionalities, specifically engineered for individual …See details»
OncoOne Company Overview, Contact Details & Competitors
Innovative Therapeutics OncoOne focuses on developing innovative therapeutics for solid tumors and inflammation, presenting a sales opportunity for healthcare providers seeking cutting-edge …See details»
OncoOne Announces Formation of Clinical Advisory Board to …
VIENNA, March 12, 2024--OncoOne, a biotechnology company focused on discovering precision medicines for cancer and autoimmune diseases, announced today the formation of a clinical …See details»
OncoOne Raises €13M Series A for First-in-Class Cancer Treatments
Mar 18, 2020 Austrian startup OncoOne has closed its first round of venture capital funding after raising €13M to investigate a new treatment target against solid tumor cancers. Investment in …See details»
OncoOne - Company Profile - Tracxn
Nov 18, 2024 OncoOne ranks 490th among 2357 active competitors. 849 of its competitors are funded while 542 have exited. Overall, OncoOne and its competitors have raised over $79.1B …See details»
Our Pipeline - OncoOne
OncoOne Aims to Deliver a Pipeline of Innovative Treatments, Overcoming Mere Symptom Relief With Curative Approaches Based on our expertise in antibody engineering, we precisely …See details»
Technology Platforms - OncoOne
OncoOne’s groundbreaking and versatile approach to direct therapeutics exclusively to diseased sites aims to change therapeutic strategies and enhance patient outcomes in cancer and …See details»
pressrelease-2021-09-15 - OncoOne
Sep 15, 2021 OncoOne US Inc. will be the base for the company’s future business development activities. “Brent has built an impressive track record in a range of key leadership positions for …See details»